<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mancini C</submitter><funding>Telethon</funding><pagination>22</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3689607</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>SCA28 is an autosomal dominant ataxia associated with AFG3L2 gene mutations. We performed a whole genome expression profiling using lymphoblastoid cell lines (LCLs) from four SCA28 patients and six unrelated healthy controls matched for sex and age.&lt;h4>Methods&lt;/h4>Gene expression was evaluated with the Affymetrix GeneChip Human Genome U133A 2.0 Arrays and data were validated by real-time PCR.&lt;h4>Results&lt;/h4>We found 66 genes whose expression was statistically different in SCA28 LCLs, 35 of which were up-regulated and 31 down-regulated. The differentially expressed genes were clustered in five functional categories: (1) regulation of cell proliferation; (2) regulation of programmed cell death; (3) response to oxidative stress; (4) cell adhesion, and (5) chemical homeostas</pubmed_abstract><journal>BMC medical genomics</journal><pubmed_title>Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways.</pubmed_title><pmcid>PMC3689607</pmcid><funding_grant_id>GGP07110</funding_grant_id><funding_grant_id>GGP12217</funding_grant_id><pubmed_authors>Mancini C</pubmed_authors><pubmed_authors>Roncaglia P</pubmed_authors><pubmed_authors>Brice A</pubmed_authors><pubmed_authors>Brusco A</pubmed_authors><pubmed_authors>Stevanin G</pubmed_authors><pubmed_authors>Bartoletti Stella A</pubmed_authors><pubmed_authors>Cagnoli C</pubmed_authors><pubmed_authors>Le Ber I</pubmed_authors><pubmed_authors>Iommarini L</pubmed_authors><pubmed_authors>Gustincich S</pubmed_authors><pubmed_authors>Funaro A</pubmed_authors><pubmed_authors>Gasparre G</pubmed_authors><pubmed_authors>Maltecca F</pubmed_authors><pubmed_authors>Calvaruso MA</pubmed_authors><pubmed_authors>Brussino A</pubmed_authors><pubmed_authors>Gazzano E</pubmed_authors><pubmed_authors>Porcelli AM</pubmed_authors><pubmed_authors>Krmac H</pubmed_authors><pubmed_authors>Forlani S</pubmed_authors><pubmed_authors>Durr A</pubmed_authors><pubmed_authors>Ghigo D</pubmed_authors><pubmed_authors>Casari G</pubmed_authors><pubmed_authors>Lo Buono N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathways.</name><description>&lt;h4>Background&lt;/h4>SCA28 is an autosomal dominant ataxia associated with AFG3L2 gene mutations. We performed a whole genome expression profiling using lymphoblastoid cell lines (LCLs) from four SCA28 patients and six unrelated healthy controls matched for sex and age.&lt;h4>Methods&lt;/h4>Gene expression was evaluated with the Affymetrix GeneChip Human Genome U133A 2.0 Arrays and data were validated by real-time PCR.&lt;h4>Results&lt;/h4>We found 66 genes whose expression was statistically different in SCA28 LCLs, 35 of which were up-regulated and 31 down-regulated. The differentially expressed genes were clustered in five functional categories: (1) regulation of cell proliferation; (2) regulation of programmed cell death; (3) response to oxidative stress; (4) cell adhesion, and (5) chemical homeostas</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Jun</publication><modification>2026-05-30T12:57:59.853Z</modification><creation>2026-04-08T07:18:56.417Z</creation></dates><accession>S-EPMC3689607</accession><cross_references><pubmed>23777634</pubmed><doi>10.1186/1755-8794-6-22</doi></cross_references></HashMap>